Back

Sex differences in thromboembolic risk and anticoagulant management in patients with non-valvular atrial fibrillation: a systematic review

30 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Prevalence and incidence of atrial fibrillation: risk stratification Stroke in Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Vaneeza Khan

(United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Postoperative atrial fibrillation as a marker of atrial myopathy in aortic stenosis: a prospective surgical cohort analysis
Doctor L. Cristin (Quebec, CA)
Abstract Slides
Presentation thumbnail
POAF duration modifies long-term stroke prediction by the CHA₂DS₂-VASc score after cardiac surgery
Doctor A. Taseva Vasileva (Skopje, MK)
Abstract Slides
Presentation thumbnail
Panoramic vs. empiric mapping in the diagnosis and treatment of persistent atrial fibrillation - meta analysis
Doctor R. Gagyi (Szeged, HU)
Abstract Slides
Presentation thumbnail
Identification of the mapping-based voltage-derived parameter for accurate arrhythmia outcome prediction in patients undergoing a first PVI
Doctor T. Huang (Lucerne, CH)
Abstract Slides
Presentation thumbnail
Type 2 diabetes and atrial fibrillation: triangulation of observational, genetic, and trial evidence
Mr A. Von Ende (Oxford, GB)

Access the full session

Session thumbnail
Prevalence and incidence of atrial fibrillation: risk stratification

The Event

Event poster

ESC Congress 2026

30 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Sex differences in the use of rhythm control strategies in patients with atrial fibrillation in FinACAF study
29 August 2022
thumbnail
Congress Presentation
Comparative characteristics of anticoagulants used in cancer-associated thrombosis
20 June 2025
thumbnail
Congress Presentation
Risk of dementia in patients treated with non-vitamin k antagonist oral anticoagulant or warfarin for nonvalvular atrial fibrillation
31 August 2019
thumbnail
Congress Presentation
Sex-based differences in VA-ECMO patients: gender gap or selection bias?
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources